Steven Cohen Novo Nordisk A S Call Options Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $15.6 Million - $19 Million	130,800 Added 787.95%	147,400 $17.6 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $12.3 Million - $14.7 Million	-100,000 Reduced 85.76%	16,600 $2.37 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $1.7 Million - $2.26 Million	16,600 Added 16.6%	116,600 $15 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $8.78 Million - $10.5 Million	100,000 New	100,000 $10.3 Million

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.